Literature DB >> 21984735

High plasma interleukin-18 levels mark the acute phase of hepatitis C virus infection.

Michael A Chattergoon1, Jordana S Levine, Rachel Latanich, William O Osburn, David L Thomas, Andrea L Cox.   

Abstract

BACKGROUND: Proinflammatory cytokines play a critical role in antiviral immune responses. Large-scale genome studies have found correlations between single-nucleotide polymorphisms (SNPs) in the interleukin (IL) 18 promoter and spontaneous control of hepatitis C virus (HCV), suggesting a role in clearance.
METHODS: Plasma IL-18, IL-1β, IL-6, IL-8, IL-12, interferon-γ, tumor necrosis factor-α, alanine aminotransferase (ALT), and HCV RNA levels were assessed longitudinally in subjects with known dates of HCV acquisition and analyzed according to IL-18 SNPs and outcome, either spontaneous clearance (SC) (n = 13) or persistent infection (PI) (n = 25).
RESULTS: No significant change in plasma proinflammatory cytokine expression was observed with the exception of IL-18, which increased in every subject with initial detection of HCV RNA. In every SC subject, IL-18 returned to the preinfection baseline concomitant with HCV control. In PI subjects, IL-18 declined following the acute phase of infection but remained above the preinfection baseline throughout chronic infection and did not correlate with HCV RNA or ALT levels.
CONCLUSIONS: Plasma IL-18 was an early and the most reliably detected host response to HCV infection measured in blood. Reduced IL-18 production with transition to chronic infection without correlation with HCV RNA or ALT levels suggests modulation of the innate response with persistent infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21984735      PMCID: PMC3203233          DOI: 10.1093/infdis/jir642

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  25 in total

1.  DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection.

Authors:  C B Bigger; K M Brasky; R E Lanford
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  Hepatitis C: global prevalence.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  1997-11-14

3.  Association between plasma interleukin-18 levels and liver injury in chronic hepatitis C virus infection and non-alcoholic fatty liver disease.

Authors:  Jacopo Vecchiet; Katia Falasca; Pierluigi Cacciatore; Pompea Zingariello; Margherita Dalessandro; Marina Marinopiccoli; Emilio D'Amico; Carlo Palazzi; Claudia Petrarca; Pio Conti; Eligio Pizzigallo; Maria Teresa Guagnano
Journal:  Ann Clin Lab Sci       Date:  2005       Impact factor: 1.256

4.  Prospective evaluation of community-acquired acute-phase hepatitis C virus infection.

Authors:  Andrea L Cox; Dale M Netski; Timothy Mosbruger; Susan G Sherman; Steffanie Strathdee; Danielle Ompad; David Vlahov; David Chien; Venkatakrishna Shyamala; Stuart C Ray; David L Thomas
Journal:  Clin Infect Dis       Date:  2005-03-03       Impact factor: 9.079

5.  Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees.

Authors:  Catherine B Bigger; Bernadette Guerra; Kathleen M Brasky; Gene Hubbard; Michael R Beard; Bruce A Luxon; Stanley M Lemon; Robert E Lanford
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

6.  Cloning of a new cytokine that induces IFN-gamma production by T cells.

Authors:  H Okamura; H Tsutsi; T Komatsu; M Yutsudo; A Hakura; T Tanimoto; K Torigoe; T Okura; Y Nukada; K Hattori
Journal:  Nature       Date:  1995-11-02       Impact factor: 49.962

7.  A role for plasmacytoid dendritic cells in the rapid IL-18-dependent activation of NK cells following HSV-1 infection.

Authors:  Daniel P Barr; Gabrielle T Belz; Patrick C Reading; Magdalena Wojtasiak; Paul G Whitney; William R Heath; Francis R Carbone; Andrew G Brooks
Journal:  Eur J Immunol       Date:  2007-05       Impact factor: 5.532

8.  Vaccinia virus interleukin-18-binding protein promotes virulence by reducing gamma interferon production and natural killer and T-cell activity.

Authors:  Patrick C Reading; Geoffrey L Smith
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

Review 9.  The interferon inducing pathways and the hepatitis C virus.

Authors:  Eliane F Meurs; Adrien Breiman
Journal:  World J Gastroenterol       Date:  2007-05-07       Impact factor: 5.742

10.  Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice.

Authors:  Kiminori Kimura; Kazuhiro Kakimi; Stefan Wieland; Luca G Guidotti; Francis V Chisari
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

View more
  29 in total

1.  Monocytes activate natural killer cells via inflammasome-induced interleukin 18 in response to hepatitis C virus replication.

Authors:  Elisavet Serti; Jens M Werner; Michael Chattergoon; Andrea L Cox; Volker Lohmann; Barbara Rehermann
Journal:  Gastroenterology       Date:  2014-03-28       Impact factor: 22.682

2.  Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis.

Authors:  Daniel Sepulveda-Crespo; Salvador Resino; Isidoro Martinez
Journal:  Drugs       Date:  2021-01-05       Impact factor: 9.546

3.  Systemic Elevation of Proinflammatory Interleukin 18 in HIV/HCV Coinfection versus HIV or HCV Monoinfection.

Authors:  Rebecca T Veenhuis; Jacquie Astemborski; Michael A Chattergoon; Paige Greenwood; Marissa Jarosinski; Richard D Moore; Shruti H Mehta; Andrea L Cox
Journal:  Clin Infect Dis       Date:  2016-12-07       Impact factor: 9.079

4.  Intra-Hepatic Depletion of Mucosal-Associated Invariant T Cells in Hepatitis C Virus-Induced Liver Inflammation.

Authors:  Fabian J Bolte; Ashley C O'Keefe; Lauren M Webb; Elisavet Serti; Elenita Rivera; T Jake Liang; Marc Ghany; Barbara Rehermann
Journal:  Gastroenterology       Date:  2017-08-02       Impact factor: 22.682

5.  Temporal dynamics of inflammatory cytokines/chemokines during sofosbuvir and ribavirin therapy for genotype 2 and 3 hepatitis C infection.

Authors:  Aaron F Carlin; Paula Aristizabal; Qinghua Song; Huan Wang; Matthew S Paulson; Luisa M Stamm; Robert T Schooley; David L Wyles
Journal:  Hepatology       Date:  2015-08-22       Impact factor: 17.425

6.  Hepatitis C virus induces interleukin-1β (IL-1β)/IL-18 in circulatory and resident liver macrophages.

Authors:  Shubham Shrivastava; Anupam Mukherjee; Ranjit Ray; Ratna B Ray
Journal:  J Virol       Date:  2013-09-04       Impact factor: 5.103

7.  Interferon γ-induced protein 10 kinetics in treatment-naive versus treatment-experienced patients receiving interferon-free therapy for hepatitis C virus infection: implications for the innate immune response.

Authors:  Jennifer C Lin; François Habersetzer; Maribel Rodriguez-Torres; Nezam Afdhal; Eric J Lawitz; Matthew S Paulson; Yanni Zhu; Gangadharan Mani Subramanian; John G McHutchison; Mark Sulkowski; David L Wyles; Robert T Schooley
Journal:  J Infect Dis       Date:  2014-06-06       Impact factor: 5.226

8.  Spontaneous clearance of primary acute hepatitis C virus infection correlated with high initial viral RNA level and rapid HVR1 evolution.

Authors:  Lin Liu; Brian E Fisher; David L Thomas; Andrea L Cox; Stuart C Ray
Journal:  Hepatology       Date:  2012-04-18       Impact factor: 17.425

Review 9.  Innate immune cell networking in hepatitis C virus infection.

Authors:  Banishree Saha; Gyongyi Szabo
Journal:  J Leukoc Biol       Date:  2014-07-07       Impact factor: 4.962

10.  Anti-inflammatory cytokines, pro-fibrogenic chemokines and persistence of acute HCV infection.

Authors:  W O Osburn; J S Levine; M A Chattergoon; D L Thomas; A L Cox
Journal:  J Viral Hepat       Date:  2013-02-06       Impact factor: 3.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.